drugset / Trial / NCT00908583
Desensitization in Kidney Transplantation
Non-randomizedSingle-groupOpen-labelTreatment
Summary
To determine if deletional strategies will provide effective desensitization.
Timeline
- Start
- 2009-05
- Primary completion
- 2012-11
- Completion
- 2012-11
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Bortezomib | Small molecule | 1.3 mg/m2 | Intravenous |
| Background | Methylprednisolone | Other / unclassified | 50 mg | Intravenous |
| Background | Rituximab | Monoclonal antibody | 375 mg/m2 | — |